Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the MDM2-p53 protein-protein interaction with prenylchalcones: Synthesis of a small library and evaluation of potential antitumor activity
Pedro Brandão, Joana B. Loureiro, Sylvie Carvalho, et al.
European Journal of Medicinal Chemistry (2018) Vol. 156, pp. 711-721
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Role of p53 in breast cancer progression: An insight into p53 targeted therapy
Charlie Marvalim, Arpita Datta, Soo Chin Lee
Theranostics (2023) Vol. 13, Iss. 4, pp. 1421-1442
Open Access | Times Cited: 85
Synthesis and Anticancer Activity of Benzimidazole and Benzothiazole Derivatives Bearing Furan Moiety by CAN as a Catalyst Under Ultrasonic Irradiation and Molecular Docking Studies
Elahe Mashhadi, Javad Safaei‐Ghomi, Muhammad E. Yahya
ChemistrySelect (2025) Vol. 10, Iss. 2
Closed Access
Development of selective small molecule MDM2 degraders based on nutlin
Bo Wang, Suzhen Wu, Jin Liu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 476-491
Closed Access | Times Cited: 64
Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors
Aladdin M. Srour, Nesreen S. Ahmed, Somaia S. Abd El‐Karim, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 18, pp. 115657-115657
Closed Access | Times Cited: 50
Chalcones and Gastrointestinal Cancers: Experimental Evidence
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 17
Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives
Bing He, Hong‐zhou Tan, Cheng‐bo Liu, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 3
Closed Access
A Comparative Study of the Anticancer Activity and PARP-1 Inhibiting Effect of Benzofuran–Pyrazole Scaffold and Its Nano-Sized Particles in Human Breast Cancer Cells
Manal M. Anwar, Somaia S. Abd El‐Karim, Ahlam H. Mahmoud, et al.
Molecules (2019) Vol. 24, Iss. 13, pp. 2413-2413
Open Access | Times Cited: 44
Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39
p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
Chahat, Rohit Bhatia, Bhupinder Kumar
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115020-115020
Closed Access | Times Cited: 22
Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity
Patrı́cia Pinto, Carmen Mariana Machado, Joana Moreira, et al.
European Journal of Medicinal Chemistry (2019) Vol. 184, pp. 111752-111752
Closed Access | Times Cited: 35
Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies
Joana Moreira, Lucı́lia Saraiva, Madalena Pinto, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112177-112177
Closed Access | Times Cited: 32
Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents
Reham A. Mohamed‐Ezzat, Aladdin M. Srour
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 544-557
Closed Access | Times Cited: 3
Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness
Joana Moreira, Joana Almeida, Lucı́lia Saraiva, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3737-3737
Open Access | Times Cited: 24
A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells
Daniel Mendanha, Joana Vieira de Castro, Joana Moreira, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3383-3383
Open Access | Times Cited: 18
New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation
Joana Moreira, Diana Ribeiro, Patrícia Silva, et al.
Molecules (2018) Vol. 24, Iss. 1, pp. 129-129
Open Access | Times Cited: 22
In VitroCharacterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell Lines
Abdulhameed Al‐Ghabkari, Aru Narendran
Cancer Biotherapy and Radiopharmaceuticals (2019) Vol. 34, Iss. 4, pp. 252-257
Closed Access | Times Cited: 18
Modeling human disease in yeast: recreating the PI3K-PTEN-Akt signaling pathway in Saccharomyces cerevisiae
Julia María Coronas-Serna, Marta Valenti, Elba del Val, et al.
International Microbiology (2019) Vol. 23, Iss. 1, pp. 75-87
Closed Access | Times Cited: 17
Chalcone derivatives as promising antifoulants: Molecular optimization, bioactivity evaluation and performance in coatings
Daniela Pereira, Andreia Palmeira, Érica Lima, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 280, pp. 116560-116560
Open Access | Times Cited: 1
A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity Evaluation
Joana Moreira, Joana Almeida, Joana B. Loureiro, et al.
ChemMedChem (2021) Vol. 16, Iss. 19, pp. 2969-2981
Closed Access | Times Cited: 9
BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity
Pedro Novais, Patrícia Silva, Joana Moreira, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7139-7139
Open Access | Times Cited: 9
A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy
Rui P.S. Patrício, Paula A. Videira, Florbela Pereira
Bioorganic & Medicinal Chemistry (2021) Vol. 53, pp. 116530-116530
Closed Access | Times Cited: 8
Structure–Activity Relationship Studies of Chalcones and Diarylpentanoids with Antitumor Activity: Potency and Selectivity Optimization
Joana Moreira, Joana B. Loureiro, Danilo Correia, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1354-1354
Open Access | Times Cited: 2
Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers
Mahmoud Alaa, Dana Elkhalifa, Feras Q. Alali, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 14, pp. 1622-1633
Closed Access | Times Cited: 6
Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor
Haifeng Gong, Juan An, Qiuxia Dong, et al.
Chemistry & Biodiversity (2019) Vol. 16, Iss. 6
Closed Access | Times Cited: 4
HETEROCYCLES 49. SYNTHESIS, CHEMICAL BEHAVIOUR AND BIOLOGICAL PROPERTIES OF HETEROCYCLIC CHALCONES. REVIEW FROM OUR RESEARCH
Denisa Leonte
FARMACIA (2021) Vol. 69, Iss. 5, pp. 821-836
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top